Select Medical Holdings Corporation (SEM)
NYSE: SEM · Real-Time Price · USD
16.80
-0.23 (-1.35%)
Mar 28, 2025, 4:00 PM EDT - Market closed
Select Medical Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Revenue | 5,187 | 4,826 | 4,609 | 6,205 | 5,532 | Upgrade
|
Revenue Growth (YoY) | 7.48% | 4.70% | -25.71% | 12.16% | 1.43% | Upgrade
|
Cost of Revenue | 4,272 | 3,990 | 3,954 | 4,941 | 4,374 | Upgrade
|
Gross Profit | 915.54 | 836.47 | 655.59 | 1,264 | 1,157 | Upgrade
|
Selling, General & Admin | 507.76 | 435.06 | 407.13 | 491.12 | 474.09 | Upgrade
|
Other Operating Expenses | -3.41 | -1.52 | - | -0.33 | - | Upgrade
|
Operating Expenses | 647.22 | 569.23 | 539.29 | 693.43 | 679.75 | Upgrade
|
Operating Income | 268.32 | 267.24 | 116.3 | 570.07 | 477.65 | Upgrade
|
Interest Expense | -128.61 | -154.17 | -137.47 | -135.99 | -153.01 | Upgrade
|
Interest & Investment Income | - | - | - | 5.35 | - | Upgrade
|
Earnings From Equity Investments | 63.9 | 41.34 | 27.98 | 44.43 | 29.44 | Upgrade
|
EBT Excluding Unusual Items | 203.61 | 154.42 | 6.81 | 483.87 | 354.07 | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | - | 2.16 | 12.39 | Upgrade
|
Legal Settlements | - | - | - | 19.9 | - | Upgrade
|
Other Unusual Items | -28.85 | -14.69 | 28.45 | 123.8 | 90.01 | Upgrade
|
Pretax Income | 174.77 | 139.72 | 35.27 | 629.72 | 456.47 | Upgrade
|
Income Tax Expense | 44.78 | 29.25 | 16.72 | 129.77 | 111.87 | Upgrade
|
Earnings From Continuing Operations | 129.99 | 110.47 | 18.55 | 499.95 | 344.61 | Upgrade
|
Earnings From Discontinued Operations | 166.72 | 189.26 | 179.48 | - | - | Upgrade
|
Net Income to Company | 296.7 | 299.73 | 198.03 | 499.95 | 344.61 | Upgrade
|
Minority Interest in Earnings | -82.67 | -56.24 | -39.03 | -97.72 | -85.61 | Upgrade
|
Net Income | 214.04 | 243.49 | 158.99 | 402.23 | 259 | Upgrade
|
Preferred Dividends & Other Adjustments | 2.32 | 2.13 | -0.53 | 13.44 | 8.9 | Upgrade
|
Net Income to Common | 211.72 | 241.36 | 159.52 | 388.79 | 250.1 | Upgrade
|
Net Income Growth | -12.10% | 53.14% | -60.47% | 55.30% | 74.47% | Upgrade
|
Shares Outstanding (Basic) | 125 | 123 | 125 | 130 | 130 | Upgrade
|
Shares Outstanding (Diluted) | 125 | 123 | 125 | 130 | 130 | Upgrade
|
Shares Change (YoY) | 1.23% | -1.22% | -4.32% | 0.36% | -0.38% | Upgrade
|
EPS (Basic) | 1.70 | 1.96 | 1.28 | 2.98 | 1.93 | Upgrade
|
EPS (Diluted) | 1.70 | 1.96 | 1.28 | 2.98 | 1.93 | Upgrade
|
EPS Growth | -13.35% | 53.18% | -57.12% | 54.90% | 75.01% | Upgrade
|
Free Cash Flow | 295.69 | 352.86 | 94.45 | 220.69 | 881.63 | Upgrade
|
Free Cash Flow Per Share | 2.37 | 2.87 | 0.76 | 1.69 | 6.79 | Upgrade
|
Dividend Per Share | 0.438 | 0.500 | 0.500 | 0.500 | - | Upgrade
|
Dividend Growth | -12.50% | - | - | - | - | Upgrade
|
Gross Margin | 17.65% | 17.33% | 14.22% | 20.36% | 20.92% | Upgrade
|
Operating Margin | 5.17% | 5.54% | 2.52% | 9.19% | 8.63% | Upgrade
|
Profit Margin | 4.08% | 5.00% | 3.46% | 6.27% | 4.52% | Upgrade
|
Free Cash Flow Margin | 5.70% | 7.31% | 2.05% | 3.56% | 15.94% | Upgrade
|
EBITDA | 411.18 | 402.93 | 248.46 | 772.72 | 683.3 | Upgrade
|
EBITDA Margin | 7.93% | 8.35% | 5.39% | 12.45% | 12.35% | Upgrade
|
D&A For EBITDA | 142.87 | 135.69 | 132.16 | 202.65 | 205.66 | Upgrade
|
EBIT | 268.32 | 267.24 | 116.3 | 570.07 | 477.65 | Upgrade
|
EBIT Margin | 5.17% | 5.54% | 2.52% | 9.19% | 8.63% | Upgrade
|
Effective Tax Rate | 25.62% | 20.94% | 47.42% | 20.61% | 24.51% | Upgrade
|
Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.